RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Research

Contracts to Mitigate Risks from Ultra High-Cost Drugs

Learn about the new financing models being used to mitigate financial risk for ultra-high-cost drugs and get transformative therapies to patients.

Overview


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

1. You'll know why ultra-high-cost drugs are important.

2. You'll understand performance-based agreements and other models for mitigating financial risk.

3. You'll get a reality check on the difficulty of executing these contracts properly.

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.